Louis Pasteur’s S-Necked Flask Experiment

Significance and Impact

• Experiment Overview: Pasteur used S-shaped (swan-necked) flasks containing nutrient broth. After boiling, the broth remained free of microbial growth unless the flask was tilted or the neck broken, allowing airborne particles to enter.

• Importance: Disproved spontaneous generation by demonstrating that microorganisms come from other microbes, not from non-living matter.

• Impact: Laid the foundation for aseptic techniques and the germ theory of disease.

• Example: The experiment showed that sterilized broth in an intact S-necked flask did not spoil, but exposure to air led to contamination.

Koch’s Postulates

Principles and Application

• Postulate 1: The suspected pathogen must be present in all cases of the disease and absent from healthy organisms.

• Postulate 2: The pathogen must be isolated from the diseased host and grown in pure culture.

• Postulate 3: The cultured pathogen must cause the same disease when introduced into a healthy, susceptible host.

• Postulate 4: The pathogen must be re-isolated from the experimentally infected host and shown to be the same as the original organism.

• Application: These postulates are used to establish causative relationships between microbes and diseases, though there are exceptions (e.g., viruses that cannot be cultured, asymptomatic carriers).

Binomial Nomenclature

Scientific Naming Conventions

• Format: Genus name (capitalized) + species name (lowercase), both italicized (e.g., Escherichia coli).

• Rules: After first use, genus can be abbreviated (e.g., E. coli).

Staining Techniques

Acid-Fast Stain

• Principle: Differentiates bacteria with waxy mycolic acid in their cell walls (e.g., Mycobacterium).

• Steps: Primary stain (carbol fuchsin), heat, acid-alcohol decolorizer, counterstain (methylene blue).

• Usefulness: Identifies acid-fast bacteria, important in diagnosing tuberculosis and leprosy.

Gram Stain

• Steps: Crystal violet, iodine (mordant), alcohol (decolorizer), safranin (counterstain).

• Results: Gram-positive (purple), Gram-negative (pink/red).

• Troubleshooting: Omitting decolorizer leads to all cells appearing Gram-positive; omitting mordant may cause poor retention of crystal violet.

Bacterial Culturing Techniques

Streak Plate Technique

• Purpose: Isolates individual bacterial colonies from a mixed sample.

• Method: Sequentially streaking a loop across agar to dilute cells.

• Colony: A visible mass of cells derived from a single progenitor cell.

Bacterial Cell Morphology

Shapes and Arrangements

• Shapes: Cocci (spherical), bacilli (rod-shaped), spirilla (spiral), vibrio (comma-shaped), spirochetes (flexible spirals).

• Arrangements: Chains (strepto-), clusters (staphylo-), pairs (diplo-), tetrads, palisades.

Extracellular Structures

• Flagella: Motility structures; arrangements include monotrichous, lophotrichous, amphitrichous, peritrichous.

• Pili/Fimbriae: Attachment and conjugation.

• Capsules: Protective polysaccharide layers aiding in immune evasion.

Endospores

• Features: Highly resistant, dormant structures formed by genera such as Bacillus and Clostridium.

• Function: Survival under harsh conditions (heat, desiccation, chemicals).

Prokaryotic vs. Eukaryotic Cells

Comparison

• Prokaryotes: No nucleus, circular DNA, 70S ribosomes, no membrane-bound organelles.

• Eukaryotes: Nucleus, linear DNA, 80S ribosomes, membrane-bound organelles (mitochondria, ER, Golgi, etc.).

Eukaryotic Organelles

• Nucleus: Contains DNA.

• Mitochondria: ATP production via cellular respiration.

• Endoplasmic Reticulum (ER): Protein and lipid synthesis.

• Golgi Apparatus: Protein modification and sorting.

Bacterial Intracellular Features

• Genome: Single, circular chromosome in nucleoid region; plasmids may be present.

• Ribosomes: 70S, site of protein synthesis.

Taxonomic Kingdoms

Features and Classification

• Animalia: Multicellular, heterotrophic, no cell walls.

• Plantae: Multicellular, autotrophic, cell walls of cellulose.

• Fungi: Unicellular/multicellular, chitin cell walls, decomposers.

• Protista: Mostly unicellular, diverse nutrition and structure.

• Bacteria: Prokaryotic, peptidoglycan cell walls.

• Archaea: Prokaryotic, unique membrane lipids, often extremophiles.

Fungal Infections

Ringworm and Mycoses

• Ringworm: Superficial fungal infection (dermatophytosis) affecting skin, hair, or nails.

• Mycoses: Fungal diseases; can be challenging due to eukaryotic nature of fungi, making selective treatment difficult.

Genetics: DNA and RNA

Structure and Function

• DNA: Double helix, deoxyribose sugar, bases A-T-G-C.

• RNA: Single-stranded, ribose sugar, bases A-U-G-C.

• Epigenome: Chemical modifications to DNA/histones affecting gene expression without altering sequence.

DNA Replication

• Enzymes: Helicase (unwinds), primase (RNA primer), DNA polymerase (synthesizes new strand), ligase (joins fragments).

• Process: Semi-conservative; each new DNA has one old and one new strand.

Protein Synthesis

• Transcription: DNA to mRNA in nucleus (eukaryotes) or cytoplasm (prokaryotes).

• Translation: mRNA to protein at ribosome.

Horizontal Gene Transfer in Bacteria

• Transformation: Uptake of naked DNA from environment.

• Transduction: Transfer via bacteriophages.

• Conjugation: Direct transfer via pilus.

Mutations

• Types: Point mutations (silent, missense, nonsense), insertions, deletions, frameshifts.

• Outcomes: Can be neutral, beneficial, or harmful.

Viruses and Prions

Nature of Viruses

• Non-living: Lack metabolism, cannot reproduce independently, require host cells.

Viral Replication Stages

• Attachment, penetration, uncoating, biosynthesis, assembly, release.

• Antiviral Targets: Entry inhibitors, polymerase inhibitors, protease inhibitors, release inhibitors.

Viral Structure

• Components: Nucleic acid (DNA or RNA), capsid, envelope (in some viruses), spikes.

Viral Release Mechanisms

• Budding: Enveloped viruses acquire membrane from host during exit.

• Lysis: Non-enveloped viruses rupture host cell.

Types of Infections

• Acute: Rapid onset, short duration (e.g., influenza).

• Chronic: Persistent, ongoing replication (e.g., hepatitis B).

• Latent: Dormant periods with possible reactivation (e.g., herpes simplex).

Viral Evolution

• High Mutation Rates: Especially in RNA viruses due to lack of proofreading.

• Genetic Drift: Small, gradual changes in genome.

• Genetic Shift: Major changes via reassortment (e.g., influenza pandemics).

Oncogenic Viruses

• Definition: Viruses that can cause cancer (e.g., HPV, EBV).

Prions

• Nature: Infectious proteins causing neurodegenerative diseases (e.g., Creutzfeldt-Jakob disease, mad cow disease).

Microbial Metabolism

Catabolic vs. Anabolic Reactions

• Catabolism: Breakdown of molecules to release energy.

• Anabolism: Synthesis of complex molecules from simpler ones, requiring energy.

• Interconnection: Catabolic reactions provide energy and building blocks for anabolic reactions.

Enzymes and Coenzymes

• Enzymes: Biological catalysts, usually proteins, that speed up reactions by lowering activation energy.

• Coenzymes: Non-protein molecules (often vitamins) that assist enzymes (e.g., NAD+, FAD).

Cellular Respiration Pathways

• Glycolysis: Occurs in cytoplasm; input: glucose; output: 2 pyruvate, 2 ATP, 2 NADH.

• Intermediate Step: Pyruvate to acetyl-CoA; CO2 released; NADH produced.

• Krebs Cycle: Mitochondrial matrix (eukaryotes); input: acetyl-CoA; output: CO2, NADH, FADH2, ATP.

• Electron Transport Chain: Inner mitochondrial membrane (eukaryotes); produces most ATP via oxidative phosphorylation.

Aerobic vs. Anaerobic Respiration

• Aerobic: Final electron acceptor is O2; higher ATP yield.

• Anaerobic: Final electron acceptor is not O2 (e.g., nitrate, sulfate); lower ATP yield.

Fermentation

• Definition: Anaerobic process regenerating NAD+ for glycolysis; produces organic end products (e.g., lactic acid, ethanol).

• Benefits: Allows ATP production without oxygen.

Pathogenicity and Epidemiology

Pathogen Types

• True Pathogen: Causes disease in healthy hosts.

• Opportunistic Pathogen: Causes disease in immunocompromised or when introduced to unusual sites.

Key Epidemiological Terms

Antiseptics, Disinfectants, and Microbial Control

Oxygen Requirements in Bacteria

Physical Growth Requirements

Medical Equipment and Germicides

Emerging and Reemerging Pathogens

• Emerging Pathogen: Newly identified or previously rare.

• Reemerging Pathogen: Previously controlled but increasing in incidence.

Pathogen Sources and Transmission

• Exogenous Pathogen: Originates outside the host.

• Endogenous Pathogen: Originates from host’s own flora.

• Normal Flora: Microbes normally present in/on the body.

• Biological Vector: Organism that transmits pathogen and is part of its life cycle (e.g., mosquito for malaria).

• Mechanical Vector: Transmits pathogen without being infected (e.g., fly carrying bacteria on feet).

• Source: Immediate origin of infection.

• Reservoir: Long-term host or environment where pathogen persists.

• Asymptomatic Carrier: Infected but shows no symptoms.

• Chronic Carrier: Harbors pathogen long-term.

Morbidity and Mortality

• Morbidity: Incidence of disease in a population.

• Mortality: Incidence of death from disease.

ID50 and LD50

• ID50: Infectious dose for 50% of population.

• LD50: Lethal dose for 50% of population.

Toxemia and Ribozymes

• Toxemia: Presence of toxins in the blood.

• Ribozymes: RNA molecules with catalytic activity.

Infectious Disease Transmission

Direct vs. Indirect Mechanisms

• Direct Transmission: Person-to-person contact (e.g., touching, droplets).

• Indirect Transmission: Via fomites, vectors, or contaminated food/water.

Culture Media Types

Healthcare-Associated Infections (HAIs)

• Definition: Infections acquired in healthcare settings.

• Examples: MRSA, C. difficile, catheter-associated urinary tract infections.

Septic Shock

• Definition: Life-threatening condition due to overwhelming infection and systemic inflammation.

• Common Causes: Gram-negative bacteria (due to endotoxin/lipopolysaccharide release).

• Signs/Symptoms: Hypotension, fever, tachycardia, organ dysfunction.

Eradication of Infectious Diseases

• Criteria: No new cases globally, pathogen eliminated from environment and hosts.

• Example: Smallpox is considered eradicated.

Immune Evasion Mechanisms

• Antigenic Variation: Alteration of surface proteins to evade immune detection.

• Latency: Dormant state within host cells.

• Intracellular Survival: Hiding within host cells to avoid immune response.

Stages of Infectious Disease

Bacterial Toxins

Endotoxins vs. Exotoxins

• Endotoxins: Lipopolysaccharide (LPS) from Gram-negative outer membrane; released upon cell death; causes strong immune response.

• Exotoxins: Proteins secreted by bacteria; highly potent; can be classified into three types:

  • Type I: Superantigens (e.g., toxic shock syndrome toxin)

  • Type II: Membrane-disrupting toxins

  • Type III: A-B toxins (e.g., diphtheria toxin)

Biosafety Levels (BSL)

Diagnostic Test Performance

• Specificity: Ability to correctly identify those without the disease (true negatives).

• Sensitivity: Ability to correctly identify those with the disease (true positives).

Public Health Reporting and Disease Eradication

• Reporting Obligations: Healthcare providers must report confirmed cases of reportable diseases to public health authorities.

• Eradication Factors: No animal reservoir, effective vaccine, clear symptoms, limited transmission, strong public health infrastructure.